1. Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy
   Derek J. Erstad et al, 2018, Cancer CrossRef
2. Radix Bupleuri-Radix Paeoniae Alba Inhibits the Development of Hepatocellular Carcinoma through Activation of the PTEN/PD-L1 Axis within the Immune Microenvironment
   Fan Zhang et al, 2024, Nutrition and Cancer CrossRef
3. Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
   Mengnan Guo et al, 2021, Canadian Journal of Gastroenterology and Hepatology CrossRef
4. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology
   Huahua Tu et al, 2024, Chemical Biology & Drug Design CrossRef
5. MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
   Seyed Mostafa Parizadeh et al, 2019, Current Drug Targets CrossRef
6. Complement factor H‑related 3 overexpression affects hepatocellular carcinoma proliferation and apoptosis
   Hong Liu et al, 2019, Molecular Medicine Reports CrossRef
7. MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities
   Khadijeh Mahboobnia et al, 2024, International Journal of Molecular Sciences CrossRef
8. MicroRNA-218–5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway
   Shuang Han et al, 2019, Experimental Eye Research CrossRef
9. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma
   Bin Yu et al, 2019, Pathology - Research and Practice CrossRef
10. The Effects of Sterol-Related Signaling Pathways on Glioma
    Masoumeh Eslahi et al, 2022, Nutrition and Cancer CrossRef
11. Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
    Jieun Bang et al, 2023, Pharmaceutics CrossRef